Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

3.835

-0.175 (-4.36%)

At close: Oct 13, 2026, 4:00 PM EDT

3.850

+0.015 (0.39%)

After-hours: Oct 13, 2026, 7:59 PM EDT

Recursion Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,057	2,129	2,666	2,136	1,461	2,895
Market Cap Growth	-11.55%	-20.16%	24.83%	46.15%	-49.52%	-
Enterprise Value	1,578	1,551	2,329	1,800	1,059	2,317
Last Close Price	3.83	4.09	6.76	9.86	7.71	17.13

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	37.49	28.50	45.32	47.92	36.68	284.42
PB Ratio	2.24	1.88	2.58	4.61	3.01	5.33
P/TBV Ratio	4.36	3.23	4.85	5.70	3.02	5.35

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	28.76	20.77	39.59	40.38	26.58	227.62

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.07	0.07	0.11	0.11	0.11	0.00
Net Debt / Equity Ratio	-0.52	-0.59	-0.47	-0.74	-1.03	-0.95
Net Debt / EBITDA Ratio	1.02	1.18	1.10	1.05	2.13	2.96
Net Debt / FCF Ratio	1.36	1.76	1.30	1.14	4.14	2.60
Asset Turnover	0.04	0.05	0.06	0.07	0.06	0.02
Quick Ratio	4.67	5.20	3.43	4.24	5.51	11.27
Current Ratio	5.03	5.50	3.81	4.70	5.68	11.46
Return on Equity (ROE)	-56.58%	-59.54%	-61.90%	-69.12%	-46.56%	-47.51%
Return on Assets (ROA)	-27.33%	-27.72%	-28.48%	-32.29%	-23.42%	-25.14%
Return on Capital Employed (ROCE)	-50.30%	-48.90%	-38.00%	-62.50%	-40.90%	-32.40%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-25.23%	-30.29%	-17.39%	-15.36%	-16.39%	-6.44%
FCF Yield	-17.13%	-17.77%	-13.98%	-14.03%	-8.25%	-6.85%
Buyback Yield / Dilution	-41.13%	-63.18%	-31.92%	-18.41%	-40.04%	-475.48%

SEC Filings: 10-K · 10-Q